These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 9546996)
41. Coronary artery bypass surgery and percutaneous transluminal coronary angioplasty in patients with multivessel disease. Van Domburg RT; Saia F; Lemos PA Minerva Cardioangiol; 2003 Oct; 51(5):599-608. PubMed ID: 14551527 [TBL] [Abstract][Full Text] [Related]
42. Restenosis following percutaneous transluminal angioplasty: clinical, physiologic and pathological features. Cox JL; Gotlieb AI CMAJ; 1986 May; 134(10):1129-32. PubMed ID: 2938706 [TBL] [Abstract][Full Text] [Related]
43. Intimal hyperplasia as a cause of restenosis after percutaneous transluminal coronary angioplasty. Giraldo AA; Esposo OM; Meis JM Arch Pathol Lab Med; 1985 Feb; 109(2):173-5. PubMed ID: 3156573 [TBL] [Abstract][Full Text] [Related]
44. Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures. Landzberg BR; Frishman WH; Lerrick K Prog Cardiovasc Dis; 1997; 39(4):361-98. PubMed ID: 9050821 [TBL] [Abstract][Full Text] [Related]
45. [Endothelial dysfunction in cardiovascular diseases: therapeutic implications after coronary angioplasty]. Bauters C; Meurice T; Van Belle E; Lablanche JM; Bertrand ME Arch Mal Coeur Vaiss; 1997 Nov; 90 Spec No 6():35-9. PubMed ID: 9515112 [TBL] [Abstract][Full Text] [Related]
46. [Mechanisms of restenosis after coronary angioplasty]. Leclercq F; Grolleau R Arch Mal Coeur Vaiss; 1996 Mar; 89(3):359-65. PubMed ID: 8734189 [TBL] [Abstract][Full Text] [Related]
47. [Prospects of prevention of restenosis after coronary angioplasty]. Le Feuvre C; Tahlil O; Feldman LJ; Steg PG Ann Cardiol Angeiol (Paris); 1996; 45(7):383-8. PubMed ID: 8952733 [TBL] [Abstract][Full Text] [Related]
48. Neointimal response following rotational atherectomy compared to balloon angioplasty in a porcine model of coronary in-stent restenosis. McKenna CJ; Wilson SH; Camrud AR; Berger PB; Holmes DR; Schwartz RS Cathet Cardiovasc Diagn; 1998 Nov; 45(3):332-6. PubMed ID: 9829900 [TBL] [Abstract][Full Text] [Related]
49. Management of the patient undergoing myocardial revascularization: percutaneous transluminal coronary angioplasty. McKenna M Nurs Clin North Am; 1992 Mar; 27(1):231-42. PubMed ID: 1545990 [TBL] [Abstract][Full Text] [Related]
50. [Restenosis: physiopathology, treatments and prevention]. Lafont A; Durand E; Rahal S; de Oliveira M; Guérin Y; Fernandez F; Desnos M; Guérot C Ann Cardiol Angeiol (Paris); 1995 Sep; 44(7):349-53. PubMed ID: 8561439 [TBL] [Abstract][Full Text] [Related]
51. Restenosis after percutaneous transluminal coronary angioplasty: new therapeutic insights from pathogenic mechanisms. Berk BC; Harris K Adv Intern Med; 1995; 40():445-501. PubMed ID: 7747655 [No Abstract] [Full Text] [Related]
52. Pathogenesis of restenosis. A correlation of clinical observations with cellular responses. Haudenschild CC Z Kardiol; 1990; 79 Suppl 3():17-22. PubMed ID: 2099039 [TBL] [Abstract][Full Text] [Related]
53. [Pathophysiology and pathobiochemistry of restenosis]. Höfling B; Gonschior P; Nikol S; Bauriedel G; Welsch U; Nerlich A Z Kardiol; 1994 May; 83(5):313-8. PubMed ID: 8053238 [TBL] [Abstract][Full Text] [Related]
54. Restenosis after coronary angioplasty. Hamon M; Bauters C; McFadden EP; Wernert N; Lablanche JM; Dupuis B; Bertrand ME Eur Heart J; 1995 Aug; 16 Suppl I():33-48. PubMed ID: 8829956 [TBL] [Abstract][Full Text] [Related]
55. Mechanisms and prevention of restenosis: from experimental models to clinical practice. Bauters C; Meurice T; Hamon M; McFadden E; Lablanche JM; Bertrand ME Cardiovasc Res; 1996 Jun; 31(6):835-46. PubMed ID: 8759238 [No Abstract] [Full Text] [Related]